Search

Nature Microbiology is hiring a locum associate or senior editor (for 6 months). Apply by April 7.

Catherine M. Loc-Carrillo, MSc, PhD Director, Micro-Phage Epi Laboratory Dear phageophiles – I’m hoping that one of you has or knows someone who has Pseudomonas phi6 (ATCC 21781-B1). I’m trying to get hold of this phage so I can use it as a

The phage community may have a key role to play in the ongoing COVID-19 crisis. Patients hospitalized with respiratory viruses including flu and this current coronavirus get bacterial co-infections, and these co-infections correlate with mo

Jennifer Sun, a postdoc from the Bassler lab at Princeton, writes about how our knowledge of phage biology could aid our approach to tackle COVID-19.

Daniel Lauster (Freie Universität Berlin) and colleagues published a Nature Nanotechnology paper showing their use of phage capsid nanoparticles to block influenza virus entry into cells, leading to inhibition of infection in vitro and in v

Nikoline Olsen and colleagues at Aarhus University published a preprint on a new high throughput screening method (HITS) for isolating distinct phages at a large scale against multiple hosts.

Nathan Porter (University of Michigan) and colleagues published a new preprint on how phase-variable mechanisms alter phage susceptibility in Bacteroides thetaiotaomicron.

BiomX announced positive results from its Phase 1 randomized, double-blind, placebo-controlled cosmetic clinical study in 75 subjects with mild to moderate acne. Their phage product (a topical gel comprised of a cocktail of naturally-occurr

Amit Vikram (Intralytix, Inc) and colleagues published a paper showing that their company's EcoShield phage cocktail reduces E. coli O157:H7 levels by 97% in eight types of foods (including meats, fish, cheese and lettuce), including reduci

HHMI's Science Education Alliance, Gene-function Exploration by a Network of Emerging Scientists (SEA-GENES) project is designed to expand the work conducted in the SEA-PHAGES course. In the SEA-GENES project, students will generate express

A couple of phage therapy podcasts for you this week: one with John Haverty, who received phages from Adaptive Phage Therapeutics to prevent amputation of his leg in 2019. Another with Alexander Belcredi, CEO of PhagoMed.

Bas Dutilh (Utrecht University) is looking for a Bioinformatician/Data Steward: use metagenomics to help answer questions related to the microbiome, such as predicting bacteriophage-host interactions.

Nature Microbiology is hiring a locum associate or senior editor (for 6 months). Apply by April 7.

The phage community may have a key role to play in the ongoing COVID-19 crisis. Patients hospitalized with respiratory viruses including flu and this current coronavirus get bacterial co-infections, and these co-infections correlate with mo

Catherine M. Loc-Carrillo, MSc, PhD Director, Micro-Phage Epi Laboratory Dear phageophiles – I’m hoping that one of you has or knows someone who has Pseudomonas phi6 (ATCC 21781-B1). I’m trying to get hold of this phage so I can use it as a

Karen Weynberg (University of Queensland) is hiring a PhD student for a project that aims to further the use of phage therapy by establishing an innovative synthetic biology platform to engineer phage therpay candidates within a biofoundry.

BiomX announced positive results from its Phase 1 randomized, double-blind, placebo-controlled cosmetic clinical study in 75 subjects with mild to moderate acne. Their phage product (a topical gel comprised of a cocktail of naturally-occurr

A couple of phage therapy podcasts for you this week: one with John Haverty, who received phages from Adaptive Phage Therapeutics to prevent amputation of his leg in 2019. Another with Alexander Belcredi, CEO of PhagoMed.

Jennifer Sun, a postdoc from the Bassler lab at Princeton, writes about how our knowledge of phage biology could aid our approach to tackle COVID-19.

Daniel Lauster (Freie Universität Berlin) and colleagues published a Nature Nanotechnology paper showing their use of phage capsid nanoparticles to block influenza virus entry into cells, leading to inhibition of infection in vitro and in v